For the quarter ending 2025-09-30, ICCC made $5,506,122 in revenue. -$139,748 in net income. Net profit margin of -2.54%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Product sales | 5,506,122 | 6,444,880 | 8,067,174 | 8,385,349.75* |
| Costs of goods sold | 3,143,024 | 3,626,956 | 4,713,202 | 4,638,031.25* |
| Gross margin | 2,363,098 | 2,817,924 | 3,353,972 | 3,747,318.5* |
| Sales and marketing expenses | 919,291 | 696,086 | 856,658 | 722,569* |
| Product development expenses | 694,311 | 831,858 | 756,847 | 1,173,625* |
| Administrative expenses | 729,421 | 720,418 | 622,843 | 521,697.5* |
| Operating expenses | 2,343,023 | 2,248,362 | 2,236,348 | 2,417,891.5* |
| Net operating income (gain) | 20,075 | 569,562 | 1,117,624 | 1,329,427* |
| Other (expenses) income, net | -155,367 | -65,778 | 331,263 | -130,046* |
| (gain) income before income taxes | -135,292 | 503,784 | 1,448,887 | 1,199,381* |
| Income tax expense | 4,456 | 1,904 | 1,904 | 6,036* |
| Net (gain) income | -139,748 | 501,880 | 1,446,983 | 1,193,345 |
| Basic EPS | -0.02 | 0.06 | 0.16 | 0.14 |
| Diluted EPS | -0.02 | 0.06 | 0.16 | 0.14 |
| Basic Average Shares | 9,045,851 | 9,031,282 | 8,980,602 | 8,527,272 |
| Diluted Average Shares | 9,045,851 | 9,031,282 | 8,980,602 | 8,527,272 |
IMMUCELL CORP DE (ICCC)
IMMUCELL CORP DE (ICCC)